{"id":1760,"date":"2024-03-19T13:26:00","date_gmt":"2024-03-19T12:26:00","guid":{"rendered":"https:\/\/pharmameldrugdiscovery.com\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/"},"modified":"2024-07-02T14:01:17","modified_gmt":"2024-07-02T12:01:17","slug":"pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment","status":"publish","type":"post","link":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/","title":{"rendered":"Pharmamel begins the path to going public, entering the BME pre-market environment."},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Pharmamel announces an imminent Pre-IPO capital increase campaign on the CNMV-regulated platform Capital Cell.<\/strong><\/p>\n\n<p class=\"wp-block-paragraph\"><strong>Granada, March 19, 2024.- Pharmamel, <\/strong>the Spin-off and <strong>biotechnological Start-Up <\/strong>from the University of Granada is at a <strong>key moment of growth and development, both on the corporate and scientific fronts, <\/strong>as <strong>the company has started the process to go public on the BME Scaleup<\/strong>, signing a strategic agreement with <strong>the registered advisor Armabex, a subsidiary of the Armanext group,<\/strong> and entering the <strong>pre-market environment of Bolsa y Mercados Espa\u00f1oles (BME)<\/strong>, where Pharmamel is expected to go public in the fourth quarter of 2024.&#13;\n&#13;\nOn the scientific front<strong>, the company faces the significant challenge of completing a Phase III clinical trial in Europe and the USA, since the renowned biotechnological firm from Granada<\/strong> possesses a valuable technology: a novel intravenous melatonin drug capable of counteracting and treating Sepsis (the leading cause of hospital death worldwide). After<strong> demonstrating the effectiveness, efficacy, and safety of the new drug in two Phase II clinical trials.<\/strong>&#13;\n&#13;\nFollowing the clinical results obtained,<strong> Pharmamel has the perfect drug candidate. Therefore, it must initiate a Phase III clinical trial and finally obtain authorization from the EMA and FDA.<\/strong>&#13;\n&#13;\nThe conduct of this trial <strong>represents a significant turning point in value for Pharmamel, as<\/strong> the acquisition of positive results in this trial (Phase IIIA), which <strong>would add to the excellent results obtained in Phase 2 studies<\/strong>, will likely grant Pharmamel and its shareholders an i<strong>ncrease in the valuation of the listed company, and the potential pre-license of the new intravenous melatonin injectable.<\/strong>&#13;\n&#13;\nTo fully fund the<strong> Phase III clinical trial in Europe and the USA<\/strong> in accordance with<strong> EMA and FDA regulations and to bring the drug to market<\/strong>, <strong>Pharmamel<\/strong> is opening a new <strong>Pre-IPO capital increase round<\/strong> on<strong> Capital Cell, a platform regulated by the CNMV<\/strong>, at a <strong>pre-money valuation of \u20ac37,000,000 before going public on the BME Scaleup,<\/strong> with an expected and estimated initial offering price of \u20ac45,000,000.&#13;\n&#13;\nThis round will likely be supplemented by <strong>CDTI, NextGenerationEU, ENISA, and other aids for which the company has already applied and requested<\/strong>, pending resolution, as well as the <strong>participation of private and specialized investors, as well as public-private investment funds<\/strong>, with whom the company has already signed pre-investment agreements\/LOIs, over a period of 6 to 12 months.&#13;\n&#13;\nAccording to company sources, the capital increase campaign will be launched next April 2024, with interested parties already able to reserve tickets and investment commitments.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmamel announces an imminent Pre-IPO capital increase campaign on the CNMV-regulated platform Capital Cell. Granada, March 19, 2024.- Pharmamel, the Spin-off and [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":1733,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1760","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-p"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmamel begins the path to going public, entering the BME pre-market environment. - Pharmamel Drug Discovery<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmamel begins the path to going public, entering the BME pre-market environment. - Pharmamel Drug Discovery\" \/>\n<meta property=\"og:description\" content=\"Pharmamel announces an imminent Pre-IPO capital increase campaign on the CNMV-regulated platform Capital Cell. Granada, March 19, 2024.- Pharmamel, the Spin-off and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharmamel Drug Discovery\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=100094009751030&amp;locale=es_ES\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-19T12:26:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-02T12:01:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pharmameldrugdiscovery.com\/wp-content\/uploads\/2024\/07\/fotonoticia_20240319130942_690.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"690\" \/>\n\t<meta property=\"og:image:height\" content=\"388\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"trevenquewp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"trevenquewp\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\\\/\"},\"author\":{\"name\":\"trevenquewp\",\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/#\\\/schema\\\/person\\\/2b2eb5128577f7b3562b5999e9ce51f5\"},\"headline\":\"Pharmamel begins the path to going public, entering the BME pre-market environment.\",\"datePublished\":\"2024-03-19T12:26:00+00:00\",\"dateModified\":\"2024-07-02T12:01:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\\\/\"},\"wordCount\":414,\"publisher\":{\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/fotonoticia_20240319130942_690.jpg\",\"articleSection\":[\"News Pharmamel\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\\\/\",\"url\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\\\/\",\"name\":\"Pharmamel begins the path to going public, entering the BME pre-market environment. - Pharmamel Drug Discovery\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/fotonoticia_20240319130942_690.jpg\",\"datePublished\":\"2024-03-19T12:26:00+00:00\",\"dateModified\":\"2024-07-02T12:01:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/fotonoticia_20240319130942_690.jpg\",\"contentUrl\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/fotonoticia_20240319130942_690.jpg\",\"width\":690,\"height\":388},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmamel begins the path to going public, entering the BME pre-market environment.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/#website\",\"url\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/\",\"name\":\"Pharmamel Drug Disvoery\",\"description\":\"Empresa biotecnol\u00f3gica de I+D+i cuya misi\u00f3n es desarrollar y poner en mercado, medicamentos innovadores basados en la melatonina.\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/#organization\"},\"alternateName\":\"Pharmamel\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/#organization\",\"name\":\"Pharmamel Drug Disvoery\",\"alternateName\":\"Pharmamel\",\"url\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cabecera-pharmamel.png\",\"contentUrl\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cabecera-pharmamel.png\",\"width\":800,\"height\":450,\"caption\":\"Pharmamel Drug Disvoery\"},\"image\":{\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=100094009751030&locale=es_ES\",\"https:\\\/\\\/www.youtube.com\\\/@PharmamelTV\\\/videos\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pharmamel\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pharmameldrugdiscovery\\\/\",\"https:\\\/\\\/pharmamel.com\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharmameldrugdiscovery.com\\\/#\\\/schema\\\/person\\\/2b2eb5128577f7b3562b5999e9ce51f5\",\"name\":\"trevenquewp\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c2a5396e415acc69ee97c21e8223a6adb8895f30afa8a89de1abd20b77496177?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c2a5396e415acc69ee97c21e8223a6adb8895f30afa8a89de1abd20b77496177?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c2a5396e415acc69ee97c21e8223a6adb8895f30afa8a89de1abd20b77496177?s=96&d=mm&r=g\",\"caption\":\"trevenquewp\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmamel begins the path to going public, entering the BME pre-market environment. - Pharmamel Drug Discovery","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/","og_locale":"en_US","og_type":"article","og_title":"Pharmamel begins the path to going public, entering the BME pre-market environment. - Pharmamel Drug Discovery","og_description":"Pharmamel announces an imminent Pre-IPO capital increase campaign on the CNMV-regulated platform Capital Cell. Granada, March 19, 2024.- Pharmamel, the Spin-off and [&hellip;]","og_url":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/","og_site_name":"Pharmamel Drug Discovery","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=100094009751030&locale=es_ES","article_published_time":"2024-03-19T12:26:00+00:00","article_modified_time":"2024-07-02T12:01:17+00:00","og_image":[{"width":690,"height":388,"url":"https:\/\/pharmameldrugdiscovery.com\/wp-content\/uploads\/2024\/07\/fotonoticia_20240319130942_690.jpg","type":"image\/jpeg"}],"author":"trevenquewp","twitter_card":"summary_large_image","twitter_misc":{"Written by":"trevenquewp","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/#article","isPartOf":{"@id":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/"},"author":{"name":"trevenquewp","@id":"https:\/\/pharmameldrugdiscovery.com\/#\/schema\/person\/2b2eb5128577f7b3562b5999e9ce51f5"},"headline":"Pharmamel begins the path to going public, entering the BME pre-market environment.","datePublished":"2024-03-19T12:26:00+00:00","dateModified":"2024-07-02T12:01:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/"},"wordCount":414,"publisher":{"@id":"https:\/\/pharmameldrugdiscovery.com\/#organization"},"image":{"@id":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/#primaryimage"},"thumbnailUrl":"https:\/\/pharmameldrugdiscovery.com\/wp-content\/uploads\/2024\/07\/fotonoticia_20240319130942_690.jpg","articleSection":["News Pharmamel"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/","url":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/","name":"Pharmamel begins the path to going public, entering the BME pre-market environment. - Pharmamel Drug Discovery","isPartOf":{"@id":"https:\/\/pharmameldrugdiscovery.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/#primaryimage"},"image":{"@id":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/#primaryimage"},"thumbnailUrl":"https:\/\/pharmameldrugdiscovery.com\/wp-content\/uploads\/2024\/07\/fotonoticia_20240319130942_690.jpg","datePublished":"2024-03-19T12:26:00+00:00","dateModified":"2024-07-02T12:01:17+00:00","breadcrumb":{"@id":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/#primaryimage","url":"https:\/\/pharmameldrugdiscovery.com\/wp-content\/uploads\/2024\/07\/fotonoticia_20240319130942_690.jpg","contentUrl":"https:\/\/pharmameldrugdiscovery.com\/wp-content\/uploads\/2024\/07\/fotonoticia_20240319130942_690.jpg","width":690,"height":388},{"@type":"BreadcrumbList","@id":"https:\/\/pharmameldrugdiscovery.com\/en\/pharmamel-begins-the-path-to-going-public-entering-the-bme-pre-market-environment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pharmameldrugdiscovery.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pharmamel begins the path to going public, entering the BME pre-market environment."}]},{"@type":"WebSite","@id":"https:\/\/pharmameldrugdiscovery.com\/#website","url":"https:\/\/pharmameldrugdiscovery.com\/","name":"Pharmamel Drug Disvoery","description":"Empresa biotecnol\u00f3gica de I+D+i cuya misi\u00f3n es desarrollar y poner en mercado, medicamentos innovadores basados en la melatonina.","publisher":{"@id":"https:\/\/pharmameldrugdiscovery.com\/#organization"},"alternateName":"Pharmamel","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharmameldrugdiscovery.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharmameldrugdiscovery.com\/#organization","name":"Pharmamel Drug Disvoery","alternateName":"Pharmamel","url":"https:\/\/pharmameldrugdiscovery.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharmameldrugdiscovery.com\/#\/schema\/logo\/image\/","url":"https:\/\/pharmameldrugdiscovery.com\/wp-content\/uploads\/2024\/07\/cabecera-pharmamel.png","contentUrl":"https:\/\/pharmameldrugdiscovery.com\/wp-content\/uploads\/2024\/07\/cabecera-pharmamel.png","width":800,"height":450,"caption":"Pharmamel Drug Disvoery"},"image":{"@id":"https:\/\/pharmameldrugdiscovery.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=100094009751030&locale=es_ES","https:\/\/www.youtube.com\/@PharmamelTV\/videos","https:\/\/www.linkedin.com\/company\/pharmamel\/","https:\/\/www.instagram.com\/pharmameldrugdiscovery\/","https:\/\/pharmamel.com\/"]},{"@type":"Person","@id":"https:\/\/pharmameldrugdiscovery.com\/#\/schema\/person\/2b2eb5128577f7b3562b5999e9ce51f5","name":"trevenquewp","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c2a5396e415acc69ee97c21e8223a6adb8895f30afa8a89de1abd20b77496177?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c2a5396e415acc69ee97c21e8223a6adb8895f30afa8a89de1abd20b77496177?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c2a5396e415acc69ee97c21e8223a6adb8895f30afa8a89de1abd20b77496177?s=96&d=mm&r=g","caption":"trevenquewp"}}]}},"_links":{"self":[{"href":"https:\/\/pharmameldrugdiscovery.com\/en\/wp-json\/wp\/v2\/posts\/1760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmameldrugdiscovery.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmameldrugdiscovery.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmameldrugdiscovery.com\/en\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmameldrugdiscovery.com\/en\/wp-json\/wp\/v2\/comments?post=1760"}],"version-history":[{"count":0,"href":"https:\/\/pharmameldrugdiscovery.com\/en\/wp-json\/wp\/v2\/posts\/1760\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmameldrugdiscovery.com\/en\/wp-json\/wp\/v2\/media\/1733"}],"wp:attachment":[{"href":"https:\/\/pharmameldrugdiscovery.com\/en\/wp-json\/wp\/v2\/media?parent=1760"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmameldrugdiscovery.com\/en\/wp-json\/wp\/v2\/categories?post=1760"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmameldrugdiscovery.com\/en\/wp-json\/wp\/v2\/tags?post=1760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}